In addition to clinical and educational duties, our Hospitalists are active in the research community and we promote discoveries through innovative research and technology. Our focus areas include; inpatient hospital care, quality improvement and medical education.

Our faculty conduct research at Stanford University and Stanford Tri-Valley and we are currently recruiting for clinical trials as part of the global response to COVID-19.

A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults
Conducting a randomized, double-blind, placebo-controlled phase 3 trial to evaluate the safety and efficacy of interferon beta-1a and remdesivir compared to remdesivir alone in hospitalized adult patients diagnosed with COVID-19. The study is sponsored by the National Institutes of Health and is a multicenter trial that will be conducted at as many as 100 sites globally.

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate The Safety And Efficacy of Tocilizumab in Patients with Severe COVID-19 Pneumonia
Conducting a randomized, double-blind, placebo-controlled phase 3 trial to evaluate the safety and efficacy of tocilizumab, an interleukin-6 receptor antibody, in hospitalized adult patients diagnosed with severe COVID-19 pneumonia. This multicenter trial is being conducted at 65 sites globally.